Abstract
ABSTRACTAimTo explore the views of SHPA pharmacist members on collaborative prescribing and the extent of de facto prescribing at their institutions.Method1367 SHPA pharmacist members were invited by mail to complete a 4–page questionnaire on current and future issues pertaining to collaborative prescribing.Results551 pharmacist members responded (40% response rate) to the survey. 509 (95%) respondents observed that a collaborative prescribing role could circumvent hospital delays with timely service delivery during the admission, inpatient, discharge and outpatient process. De facto prescribing was undertaken by 141 (37%) pharmacists across the range of drug schedules and practice settings. If a legal and credentialling framework existed, 406 (75%) pharmacists would consider becoming a ‘prescribing pharmacist’ in a specialised clinical area, while 81 (15%) were undecided and 57 (11%) would not consider the option.ConclusionSHPA pharmacist members strongly supported the development of collaborative prescribing as a means to improve patient outcomes, professional activities and standing, and hospital systems. Hospital pharmacists are undertaking a range of de facto prescribing activities.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
